Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Mallinckrodt
McKesson
Dow
Moodys

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Molybdenum

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Molybdenum?

Molybdenum is an investigational drug.

There have been 6 clinical trials for Molybdenum. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2016.

The most common disease conditions in clinical trials are Metal Metabolism, Inborn Errors, Syndrome, and Preleukemia. The leading clinical trial sponsors are Alexion Pharma GmbH, Meabco A/S, and Centre for Probe Development and Commercialization.

There are twenty-six US patents protecting this investigational drug and one hundred and sixty-eight international patents.

Recent Clinical Trials for Molybdenum
TitleSponsorPhase
Study of ALXN1101 in Neonates With Molybdenum Cofactor Deficiency (MOCD) Type AAlexion Pharma GmbHPhase 2/Phase 3
A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult PatientsCanadian Institutes of Health Research (CIHR)N/A
A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult PatientsCentre for Probe Development and CommercializationN/A

See all Molybdenum clinical trials

Clinical Trial Summary for Molybdenum

Top disease conditions for Molybdenum
Top clinical trial sponsors for Molybdenum

See all Molybdenum clinical trials

US Patents for Molybdenum

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Molybdenum   Start Trial Overbased additives for lubricant oils containing a molybdenum complex, process for preparing them and compositions containing the said additives Societe Nationale Elf Aquitaine (Courbevoie, FR)   Start Trial
Molybdenum   Start Trial Hydrodealkylation of C9+ aromatic compounds Phillips Petroleum Company (Bartlesville, OK)   Start Trial
Molybdenum   Start Trial Hydrodealkylation of C.sub.9 + aromatic compounds Phillips Petroleum Company (Bartlesville, OK)   Start Trial
Molybdenum   Start Trial Catalysts made from transition metal compounds and 4, 5-diphosphinoacridine-ligands Studiengesellschaft Kohle mbH (Mulheim an der Ruhr, DE)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Molybdenum

Drugname Country Document Number Estimated Expiration Related US Patent
Molybdenum Germany 69004163 2009-06-19   Start Trial
Molybdenum European Patent Office 0404650 2009-06-19   Start Trial
Molybdenum Spain 2060977 2009-06-19   Start Trial
Molybdenum France 2648473 2009-06-19   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Medtronic
Boehringer Ingelheim
Moodys
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.